Health ❯ Healthcare ❯ Personalized Medicine

Targeted Therapy

Radiotherapy ALK Inhibitors Molecular Characterization Early Cancer Detection Cancer Treatment Molecular Differences Driver Mutations Somatostatin-Positive Tumors

ctDNA Blood Test Guides Care as Targeted Radiotherapy Improves Control in Early Metastatic Cancer

Researchers plan follow-up trials to test ctDNA-guided decisions before routine use.

EML4-ALK V3 Proves More Aggressive and Less Drug-Sensitive Than V1 in New Study

Comprehensive NGS Study Unveils Diverse Mutational Landscape in Lung Squamous Cell Carcinoma